• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤芽生、uPA 和 PAI-1 与结肠癌的侵袭性行为有关。

Tumour budding, uPA and PAI-1 are associated with aggressive behaviour in colon cancer.

机构信息

Institute of Pathology, Klinikum Augsburg, Augsburg, Germany.

出版信息

J Surg Oncol. 2010 Sep 1;102(3):235-41. doi: 10.1002/jso.21611.

DOI:10.1002/jso.21611
PMID:20740581
Abstract

AIMS

The proteases PAI-1 and uPA play a major role in extracellular matrix degradation, which facilitates tumour progression. Tumour budding is a histomorphological expression of enhanced tumour cell migration.

MATERIALS AND METHODS

To investigate their prognostic value for and correlation with colon cancer, a prospective study was performed. We analysed tissue levels of uPA and PAI-1 of 55 colon cancer tumours employing a commercially available enzyme-linked immunosorbent assay (ELISA). Tumour budding was analysed on cytokeratin-stained slides.

RESULTS

There was a strong correlation between uPA and tumour budding (R = 0.440; P < 0.001). uPA levels were increased in high grade tumours, whereas PAI-1 was elevated in cases with venous invasion (P = 0.004 and P = 0.028). PAI-1 values and tumour budding are associated significantly with the occurrence of distant metastases (P < 0.001 and P = 0.034, respectively). Tumour budding was significantly associated with lymph node metastases (P = 0.034). Multivariate analysis revealed PAI-1 and lymph node metastases to be independently predictive of distant metastases (P = 0.007 and P = 0.004, respectively).

CONCLUSIONS

The results of our study show that tumour budding and the plasmin/plasminogen system are related. PAI-1 was independently predictive for the occurrence of distant metastasis.

摘要

目的

蛋白酶 PAI-1 和 uPA 在细胞外基质降解中起主要作用,从而促进肿瘤进展。肿瘤出芽是肿瘤细胞迁移增强的组织形态学表现。

材料与方法

为了研究其对结肠癌的预后价值及其与结肠癌的相关性,进行了一项前瞻性研究。我们采用商业上可用的酶联免疫吸附测定(ELISA)分析了 55 例结肠癌肿瘤的 uPA 和 PAI-1 组织水平。在细胞角蛋白染色的幻灯片上分析肿瘤出芽。

结果

uPA 与肿瘤出芽之间存在很强的相关性(R = 0.440;P <0.001)。高分级肿瘤中 uPA 水平升高,而静脉侵犯时 PAI-1 升高(P = 0.004 和 P = 0.028)。PAI-1 值和肿瘤出芽与远处转移的发生显著相关(P <0.001 和 P = 0.034)。肿瘤出芽与淋巴结转移显著相关(P = 0.034)。多变量分析显示 PAI-1 和淋巴结转移是远处转移的独立预测因素(P = 0.007 和 P = 0.004)。

结论

我们的研究结果表明,肿瘤出芽和纤溶酶/纤溶酶原系统有关。PAI-1 是远处转移发生的独立预测因子。

相似文献

1
Tumour budding, uPA and PAI-1 are associated with aggressive behaviour in colon cancer.肿瘤芽生、uPA 和 PAI-1 与结肠癌的侵袭性行为有关。
J Surg Oncol. 2010 Sep 1;102(3):235-41. doi: 10.1002/jso.21611.
2
Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value.口腔鳞状细胞癌患者正常组织和肿瘤组织中肿瘤相关尿激酶型纤溶酶原激活物(uPA)及其抑制剂PAI-1——临床相关性和预后价值
J Craniomaxillofac Surg. 2005 Jun;33(3):191-6. doi: 10.1016/j.jcms.2004.12.005. Epub 2005 Apr 22.
3
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.纤溶酶原激活物抑制剂-1作为乳腺癌血管重塑的一项指标
J Pathol. 2001 Sep;195(2):236-43. doi: 10.1002/path.931.
4
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.乳腺癌细胞溶质提取物中高水平的尿激酶型纤溶酶原激活剂及其抑制剂PAI-1与预后不良相关。
Cancer Res. 1993 Jun 1;53(11):2513-21.
5
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc.尿激酶(uPA)及其抑制剂PAI-1对晚期卵巢癌(国际妇产科联盟(FIGO)IIIc期)患者生存的预后意义。
Br J Cancer. 1999 Apr;79(11-12):1746-51. doi: 10.1038/sj.bjc.6690278.
6
High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma.高水平的尿激酶型纤溶酶原激活剂是胃癌患者新的预后标志物。
Cancer. 1997 Mar 1;79(5):878-83.
7
Strong prognostic impact of tumor-associated urokinase-type plasminogen activator in completely resected adenocarcinoma of the esophagus.肿瘤相关尿激酶型纤溶酶原激活剂对完全切除的食管腺癌具有强烈的预后影响。
Clin Cancer Res. 1998 Jul;4(7):1755-63.
8
Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.尿激酶型纤溶酶原激活剂与其1型抑制剂的复合物预示576例淋巴结阴性乳腺癌患者预后不良。
Cancer. 2004 Aug 1;101(3):486-94. doi: 10.1002/cncr.20374.
9
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.尿激酶型纤溶酶原激活剂及其抑制剂PAI-1在完全切除的胃癌中的预后影响
Cancer Res. 1994 Jun 1;54(11):2900-7.
10
Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus.尿激酶型纤溶酶原激活剂及其1型抑制剂对子宫颈癌预后的影响。
Cancer Res. 1994 Dec 15;54(24):6539-48.

引用本文的文献

1
The SARIFA biomarker in the context of basic research of lipid-driven cancers.脂质驱动癌症基础研究背景下的SARIFA生物标志物。
NPJ Precis Oncol. 2024 Jul 31;8(1):165. doi: 10.1038/s41698-024-00662-2.
2
Tumor budding as a potential prognostic marker in determining the behavior of primary liver cancers.肿瘤芽生作为确定原发性肝癌行为的潜在预后标志物。
World J Hepatol. 2023 Jun 27;15(6):775-785. doi: 10.4254/wjh.v15.i6.775.
3
The Role of Selected Serpins in Gastrointestinal (GI) Malignancies.特定丝氨酸蛋白酶抑制剂在胃肠道恶性肿瘤中的作用
J Clin Med. 2022 Oct 21;11(20):6225. doi: 10.3390/jcm11206225.
4
The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.尿激酶型纤溶酶原激活系统在胰腺癌中的作用:有前景的诊断和治疗靶点。
Biomolecules. 2022 Jan 18;12(2):152. doi: 10.3390/biom12020152.
5
Tumour budding in solid cancers.实体癌中的肿瘤芽生
Nat Rev Clin Oncol. 2021 Feb;18(2):101-115. doi: 10.1038/s41571-020-0422-y. Epub 2020 Sep 8.
6
DJ-1 promotes survival of human colon cancer cells under hypoxia by modulating HIF-1α expression through the PI3K-AKT pathway.DJ-1通过PI3K-AKT信号通路调节缺氧诱导因子-1α(HIF-1α)的表达,从而促进人结肠癌细胞在缺氧环境下的存活。
Cancer Manag Res. 2018 Oct 16;10:4615-4629. doi: 10.2147/CMAR.S172008. eCollection 2018.
7
Bioinformatics Analysis Reveals Most Prominent Gene Candidates to Distinguish Colorectal Adenoma from Adenocarcinoma.生物信息学分析揭示了鉴别结直肠腺瘤与腺癌最显著的候选基因。
Biomed Res Int. 2018 Aug 6;2018:9416515. doi: 10.1155/2018/9416515. eCollection 2018.
8
Interobserver variability in the H&E-based assessment of tumor budding in pT3/4 colon cancer: does it affect the prognostic relevance?在 pT3/4 结直肠癌中基于 H&E 的肿瘤芽评估中的观察者间变异性:它是否影响预后相关性?
Virchows Arch. 2018 Aug;473(2):189-197. doi: 10.1007/s00428-018-2341-1. Epub 2018 Apr 6.
9
Synergistic inhibitory effects of an engineered antibody-like molecule ATF-Fc and trastuzumab on tumor growth and invasion in a human breast cancer xenograft mouse model.工程化抗体样分子ATF-Fc与曲妥珠单抗对人乳腺癌异种移植小鼠模型肿瘤生长和侵袭的协同抑制作用
Oncol Lett. 2017 Nov;14(5):5189-5196. doi: 10.3892/ol.2017.6896. Epub 2017 Sep 6.
10
Mesenchymal Stem Cells Relevance in Multicellular Bioengineered 3D In Vitro Tumor Models.间质干细胞在多细胞生物工程三维体外肿瘤模型中的相关性。
Biotechnol J. 2017 Dec;12(12). doi: 10.1002/biot.201700079. Epub 2017 Sep 4.